Quantitative analysis of vascular to cardiac selectivity of L- and T-type voltage-operated calcium channel antagonists in human tissues

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 12, 2000, Pages 1019-1021

  Angus, Ja ^a   Sarsero, D ^a   Fujiwara, T ^a   Molenaar, P ^a   Xi, Q ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Amlopidine; Calcium antagonists; Felodipine; Human small arteries; Human trabeculae; Mibefradil; Nifedipine; Verapamil

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE; MIBEFRADIL; NIFEDIPINE; VERAPAMIL;

CARDIOVASCULAR FUNCTION; CHANNEL GATING; CONFERENCE PAPER; HEART CONDUCTION; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN TISSUE;

AORTA; ATRIAL FUNCTION; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM CHANNELS, T-TYPE; HEART; HEART ATRIA; HUMANS; ION CHANNEL GATING; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; VASA VASORUM;

EID: 0033645413     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03369.x     Document Type: Conference Paper

References (5)

1. Ro 40-5967: A new nondihydropyridine calcium channel antagonist
2. Selective block of myocardial T-type calcium channels by mibefradil: A comparison with the 1,4-dihydropyridine amlodipine
3. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists
4. Potent vasodilatory with minor cardiodepressant actions of mibefradil in human cardiac tissue
5. Nomenclature of voltagegated calcium channels